Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 11 |
GO:0031514 | motile cilium | 5 | 11 |
GO:0042995 | cell projection | 2 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 11 |
Related structures:
AlphaFold database: A4HWY6
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 12 |
GO:0005509 | calcium ion binding | 5 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.397 |
CLV_PCSK_PC1ET2_1 | 26 | 28 | PF00082 | 0.397 |
CLV_PCSK_PC7_1 | 22 | 28 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.391 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.459 |
DEG_APCC_DBOX_1 | 54 | 62 | PF00400 | 0.378 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.320 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.428 |
LIG_Actin_WH2_2 | 7 | 24 | PF00022 | 0.406 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.458 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.368 |
LIG_LIR_Gen_1 | 45 | 56 | PF02991 | 0.469 |
LIG_LIR_Gen_1 | 63 | 71 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 105 | 111 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 63 | 67 | PF02991 | 0.389 |
LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 96 | 100 | PF02991 | 0.481 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.379 |
LIG_SUMO_SIM_anti_2 | 66 | 73 | PF11976 | 0.386 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.420 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.480 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.536 |
MOD_GlcNHglycan | 75 | 79 | PF01048 | 0.440 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.374 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.390 |
MOD_N-GLC_1 | 113 | 118 | PF02516 | 0.529 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.470 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.457 |
MOD_PK_1 | 20 | 26 | PF00069 | 0.308 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.382 |
MOD_Plk_1 | 65 | 71 | PF00069 | 0.435 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.384 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.453 |
MOD_Plk_4 | 7 | 13 | PF00069 | 0.321 |
MOD_SUMO_rev_2 | 83 | 90 | PF00179 | 0.402 |
TRG_AP2beta_CARGO_1 | 45 | 55 | PF09066 | 0.412 |
TRG_DiLeu_BaEn_2 | 46 | 52 | PF01217 | 0.553 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.379 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4J8L5 | Bodo saltans | 37% | 74% |
A0A0S4KMR0 | Bodo saltans | 41% | 74% |
A0A1X0P0A5 | Trypanosomatidae | 63% | 82% |
A0A3R7KL32 | Trypanosoma rangeli | 66% | 80% |
A0A3S7WTZ3 | Leishmania donovani | 97% | 69% |
A4H8L5 | Leishmania braziliensis | 78% | 100% |
A4H8L6 | Leishmania braziliensis | 78% | 67% |
A4HWY7 | Leishmania infantum | 99% | 67% |
E9AQQ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |
E9AQQ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 67% |
Q27052 | Trypanosoma rangeli | 66% | 66% |